ResMed Inc. vs Abbvie Inc.
RMD vs ABBV — side-by-side comparison from reported financials. RMD leads 6, ABBV leads 5 of 11 comparable metrics.
ResMed Inc.
RMD · Healthcare
$230.05+1.46%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | RMD | ABBV |
|---|---|---|
| Price | $230.05 | $276.43 |
| Market cap | $32.4B | $488B |
| Revenue (TTM) | $5.65B | $64.4B |
| Revenue growth | +10.2% | +1.8% |
| Net margin | 26.9% | 9.8% |
| Free cash flow | $1.65B | $18.2B |
| Net cash (debt) | $643M | ($56.2B) |
| 1-year price return | -17.2% | +19.8% |
| P/E | 21.2 | 77.4 |
| P/E vs own history (cheap-side %) | 91% | 23% |
| Dividend yield | 1.08% | 2.45% |
| Return on equity | 24% | 96% |
| Altman Z-score | — | 2.33 |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 11,370 | 57,000 |
Full résumé-style profiles: RMD CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.